Akèy › Anplwayè › argenx US, Inc.
argenx US, Inc.: Salè H-1B ak pajon
argenx US, Inc. depoze 13 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 13. Medyèn salè yo ofri a: $180,000.
Èske argenx US, Inc. pajone visa H-1B?
argenx US, Inc. depoze 13 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Apr 16, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Drug Development Project Manager | 4 | $155,697 |
| Senior Manager, Commercial Insights | 1 | $170,000 |
| Associate Director, Safety Risk Management Lead | 1 | $195,000 |
| Senior Manager, Medical Information Customer Management | 1 | $170,000 |
| Director, Field Operations | 1 | $202,950 |
| Senior Manager, Gcp Quality | 1 | $185,650 |
| Global Patient Safety BIS Lead “ Director | 1 | $230,000 |
| Associate Director, Safety Risk Management | 1 | $212,950 |
| Clinical Quality Lead | 1 | $198,633 |
| Senior Manager, Scientific Communications | 1 | $180,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 5 | $170,000 |
| FY2025 | 4 | $172,757 |
| FY2026 | 4 | $189,316 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Data Scientists6
- Regulatory Affairs Managers4
- Regulatory Affairs Specialists1
- Market Research Analysts and Marketing Specialists1
- General and Operations Managers1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Senior Manager, Scientific Communications | $180,000 Nivo II | Boston, MA | Apr 16, 2026 | May 18, 2026 | Certifye |
| Clinical Quality Lead | $198,633 Nivo III | Boston, MA | Apr 9, 2026 | May 3, 2026 | Certifye |
| Drug Development Project Manager | $165,459 Nivo IV | Boston, MA | Mar 18, 2026 | Jul 20, 2026 | Certifye |
| Associate Director, Safety Risk Management | $212,950 Nivo IV | Boston, MA | Nov 5, 2025 | Apr 17, 2026 | Certifye |
| Drug Development Project Manager | $159,864 Nivo IV | Boston, MA | Jun 6, 2025 | Jun 23, 2025 | Certifye |
| Senior Manager, Gcp Quality | $185,650 Nivo III | Boston, MA | Mar 6, 2025 | Jun 27, 2025 | Certifye |
| Global Patient Safety BIS Lead “ Director | $230,000 Nivo IV | Boston, MA | Feb 27, 2025 | Mar 14, 2025 | Certifye |
| Drug Development Project Manager | $151,530 Nivo II | Boston, MA | Nov 21, 2024 | Mar 24, 2025 | Certifye |
| Senior Manager, Medical Information Customer Management | $170,000 Nivo IV | Boston, MA | Sep 11, 2023 | Sep 18, 2023 | Certifye |
| Director, Field Operations | $202,950 Nivo IV | Boston, MA | Aug 3, 2023 | Jan 25, 2024 | Certifye |
| Senior Manager, Commercial Insights | $170,000 Nivo IV | Boston, MA | Apr 11, 2023 | May 1, 2023 | Certifye |
| Associate Director, Safety Risk Management Lead | $195,000 Nivo IV | Sudbury, MA | Apr 5, 2023 | Apr 17, 2023 | Certifye |
| Drug Development Project Manager | $145,000 Nivo IV | Boston, MA | Nov 14, 2022 | Nov 17, 2022 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).